Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.36 |
| ▸ | KIF11 | P52732 | 1/20 | 0.35 |
| ▸ | HPGD | P15428 | 2/20 | 0.34 |
| ▸ | BCDIN3D | Q7Z5W3 | 1/20 | 0.33 |
| ▸ | BTK | Q06187 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 3/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.32 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.32 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.32 |
| ▸ | CYP2A6 | P11509 | 2/20 | 0.32 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.32 |
| ▸ | CYP1B1 | Q16678 | 1/20 | 0.32 |
| ▸ | ACACB | O00763 | 1/20 | 0.32 |
| ▸ | ACACA | Q13085 | 1/20 | 0.32 |
| ▸ | HTT | P42858 | 1/20 | 0.32 |
| ▸ | LMNA | P02545 | 1/20 | 0.32 |
| ▸ | MEN1 | O00255 | 2/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.31 |
| ▸ | POLB | P06746 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30803676 | 1.00 | L3MBTL1 (0.36) | L3MBTL1KDM4EKIF11HPGDBCDIN3D | |
| SCHEMBL4272069 | 0.81 | KDM4E (0.37) | KDM4EKIF11HPGDBCDIN3DBTK | |
| SCHEMBL161865 | 0.80 | BTK (0.48) | L3MBTL1KDM4EBTKMAPTALDH1A1 | |
| SCHEMBL29200755 | 0.79 | TRPA1 (0.34) | KDM4EMAPTALDH1A1CYP1A2MEN1 | |
| SCHEMBL13409332 | 0.76 | BTK (0.51) | L3MBTL1KDM4EBCDIN3DBTKMAPT | |
| SCHEMBL13757434 | 0.74 | BTK (0.41) | L3MBTL1HPGDBCDIN3DBTKMAPT | |
| SCHEMBL14663947 | 0.73 | L3MBTL1 (0.39) | L3MBTL1KDM4EMAPTALDH1A1HSD17B10 | |
| SCHEMBL18913911 | 0.72 | KDM4E (0.45) | L3MBTL1KDM4EMAPTALDH1A1HTT | |
| SCHEMBL4268450 | 0.71 | CYP2A6 (0.50) | KDM4EMAPTALDH1A1HSD17B10CYP2A6 | |
| SCHEMBL2229817 | 0.71 | CYP1A2 (0.37) | KDM4EKIF11ALDH1A1HSD17B10CYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2516058-B1 | HYDROFORMYLATION PROCESS | LYONDELL CHEMICAL TECH LP (US) | 2013-12-18 | — | — | EP | disclosed |
| EP-2516058-A2 | HYDROFORMYLATION PROCESS | Lyondell Chemical Technology, L.P. (US) | 2012-10-31 | — | — | EP | disclosed |
| WO-2011084268-A2 | HYDROFORMYLATION PROCESS | LYONDELL CHEMICAL TECHNOLOGY, L.P. (US) | 2011-07-14 | — | — | WO | disclosed |
| US-7790932-B1 | Hydroformylation process | LYONDELL CHEMICAL TECHNOLOGY, L.P. (US) | 2010-09-07 | — | — | US | disclosed |
| US-7049473-B2 | Hydroformylation | BASF AKTIENGESELLSCHAFT (DE) | 2006-05-23 | — | — | US | disclosed |
| EP-1486481-A2 | Hydroformylation process | BASF AKTIENGESELLSCHAFT (DE) | 2004-12-15 | — | — | EP | disclosed |
| US-20040199024-A1 | Using catalyst containing transition metal and ligand; reacting carbon monoxide and hydrogen | BASF AKTIENGESELLSCHAFT (DE) | 2004-10-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040199024-A1 | Using catalyst containing transition metal and ligand; reacting carbon monoxide and hydrogen | NUDT1, PPIP5K2, HAO2 | L3MBTL1 2717/4885KDM4E 3889/4885KIF11 4434/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.